Rondo Therapeutics, a privately held biopharmaceutical immuno-oncology company pioneering the development of next-generation T cell-engaging bispecific antibodies for the treatment of solid tumors, ...

Pfizer (PFE) and Astellas Pharma announced additional follow-up results from the Phase 3 EV-302 clinical trial evaluating the efficacy and ...

Biotech stocks are revolutionizing healthcare with breakthrough innovations, leading the charge in precision therapies and ...

Shares of solid tumor concern Zymeworks Inc. have barely budged since the company obtained its first approval. Click here to read why ZYME stock is a Hold.

From preclinical research to regulatory approval and clinical adoption, diagnostic testing underpins every stage of ADC ...

Explore the potential of monoclonal antibodies in Alzheimer’s treatment, including breakthroughs and challenges in this ...

Sutro Biopharma, Inc.’s STRO share price has dipped by 10.05%, which has investors questioning if this is right time to buy.

Invest in essential sectors like consumer staples and energy to beat inflation. See why these stocks offer reliable dividends ...

The RSU award will vest in equal annual installments on the first four anniversaries of February 15, 2025, subject to the employee’s continued service with Mersana on each such vesting date. The RSU ...

MSD began worldwide recruitment for the trial and subjects are currently being enrolled. In the randomised trial, the ...

Corbus Pharmaceuticals Holdings, Inc.’s CRBP share price has dipped by 10.18%, which has investors questioning if this is right time to buy.